IL147652A0 - Novel peptides - Google Patents

Novel peptides

Info

Publication number
IL147652A0
IL147652A0 IL14765200A IL14765200A IL147652A0 IL 147652 A0 IL147652 A0 IL 147652A0 IL 14765200 A IL14765200 A IL 14765200A IL 14765200 A IL14765200 A IL 14765200A IL 147652 A0 IL147652 A0 IL 147652A0
Authority
IL
Israel
Prior art keywords
amino acid
novel peptides
compound
activity
replaced
Prior art date
Application number
IL14765200A
Other languages
English (en)
Original Assignee
Kangawa Kenji
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kangawa Kenji filed Critical Kangawa Kenji
Publication of IL147652A0 publication Critical patent/IL147652A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
IL14765200A 1999-07-23 2000-07-24 Novel peptides IL147652A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP21000299 1999-07-23
JP33884199 1999-11-29
JP2000126623 2000-04-26
PCT/JP2000/004907 WO2001007475A1 (fr) 1999-07-23 2000-07-24 Nouveaux peptides

Publications (1)

Publication Number Publication Date
IL147652A0 true IL147652A0 (en) 2002-08-14

Family

ID=27329078

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14765200A IL147652A0 (en) 1999-07-23 2000-07-24 Novel peptides
IL147652A IL147652A (en) 1999-07-23 2002-01-15 Peptide- type compound having an activity of increasing an intracellular calcium ion concentration

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147652A IL147652A (en) 1999-07-23 2002-01-15 Peptide- type compound having an activity of increasing an intracellular calcium ion concentration

Country Status (16)

Country Link
US (5) US7385026B1 (es)
EP (3) EP2119785B1 (es)
JP (2) JP3471780B2 (es)
KR (1) KR100827973B1 (es)
CN (2) CN101693736B (es)
AT (2) ATE366813T1 (es)
AU (2) AU784035B2 (es)
BR (2) BR0012688A (es)
CA (2) CA2696819C (es)
CY (2) CY1107724T1 (es)
DE (2) DE60043361D1 (es)
DK (2) DK1795598T3 (es)
ES (3) ES2335235T3 (es)
IL (2) IL147652A0 (es)
PT (2) PT1197496E (es)
WO (1) WO2001007475A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE366813T1 (de) 1999-07-23 2007-08-15 Kenji Kangawa Neue peptide
DE60042527D1 (de) 1999-11-22 2009-08-20 Zymogenetics Inc Methode zur bildung einen peptid-rezeptor komplex mit zsig33 polypeptiden.
US6897286B2 (en) 2000-05-11 2005-05-24 Zymogenetics, Inc. Zsig33-like peptides
WO2001085804A1 (fr) 2000-05-12 2001-11-15 Kaneka Corporation Procede de purification de polymere vinylique
EP1353683A4 (en) * 2000-05-30 2004-05-12 Merck & Co Inc ANALOGS BY GHRELIN
US20020187938A1 (en) * 2000-07-24 2002-12-12 Romano Deghenghi Ghrelin antagonists
IL162780A0 (en) * 2002-04-11 2005-11-20 Kenji Kangawa Method for producing modified peptide
JP5000848B2 (ja) 2002-05-21 2012-08-15 第一三共株式会社 グレリン含有医薬組成物
WO2004009124A2 (en) * 2002-07-19 2004-01-29 Cytos Biotechnology Ag Ghrelin-carrier conjugates
ATE496940T1 (de) * 2002-07-23 2011-02-15 Ipsen Pharma Ghrelin-analoga
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
MXPA05002991A (es) * 2002-09-18 2005-10-05 Univ Montreal Ct Hospitalier Chum Analogos de ghrh.
EP1407779A1 (en) 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
CA2523576A1 (en) * 2003-04-30 2004-11-11 Kenji Kangawa Preventives or remedies for hepatopathy
WO2005016951A2 (en) * 2003-06-04 2005-02-24 Eli Lilly And Company Anti-ghrelin fab antibodies
EP1670827A2 (en) * 2003-09-05 2006-06-21 Eli Lilly And Company Anti-ghrelin antibodies
CN1321131C (zh) * 2003-12-26 2007-06-13 李宁 猪Ghrelin衍生物及其编码基因与应用
AU2005205181A1 (en) * 2004-01-20 2005-07-28 Cytos Biotechnology Ag Particle-induced ghrelin immune response
US7026175B2 (en) 2004-03-29 2006-04-11 Applied Materials, Inc. High throughput measurement of via defects in interconnects
WO2005097830A2 (en) * 2004-04-07 2005-10-20 Aditech Pharma Ab Uses of isolated binding members capable of reducing the biological activity of secretagogue compounds
WO2005097831A2 (en) * 2004-04-07 2005-10-20 Gastrotech Pharma A/S Uses of isolated binding members capable of binding specifically to secretagogues
WO2005097173A2 (en) * 2004-04-07 2005-10-20 Gastrotech Pharma A/S Use of ghrelin for the treatment of hyperthyroidism
EP1750745A1 (en) * 2004-05-11 2007-02-14 The United States of America, represented by the Secretary, Department of Health and Human Services Methods of inhibiting proinflammatory cytokine expression using ghrelin
WO2005120484A1 (ja) * 2004-06-09 2005-12-22 Kurume University グレリンの生理学的機能のレギュレーター
KR20070034583A (ko) * 2004-07-14 2007-03-28 일라이 릴리 앤드 캄파니 항-그렐린 항체
WO2006045313A2 (en) * 2004-10-27 2006-05-04 Gastrotech Pharma A/S Uses of secretagogues for treatment of organ transplant patients
EP1812044A2 (en) * 2004-10-27 2007-08-01 Gastrotech Pharma A/S Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure
JP2008521840A (ja) * 2004-11-30 2008-06-26 ガストロテック・ファルマ・アクティーゼルスカブ 成長ホルモン分泌促進物質レセプター１ａリガンド
RU2403058C2 (ru) 2005-02-23 2010-11-10 Киото Юниверсити Стимулятор регенерации панкреатических бета-клеток и продуцирования инсулина в панкреатических бета-клетках
US7479271B2 (en) 2005-02-23 2009-01-20 Eli Lilly And Company Humanized anti-ghrelin antibodies
CN101287464A (zh) 2005-09-29 2008-10-15 科学研究和应用咨询股份公司 用于刺激胃肠运动性的组合物和方法
EP1967201A4 (en) * 2005-11-21 2009-09-30 Univ Miyazaki THERAPEUTIC AGENT FOR SKIN OR SKIN REGENERATING AGENT CONTAINING DESACYL-GHRELINE OR A DERIVATIVE THEREOF AS ACTIVE INGREDIENT
CA2630006A1 (en) * 2005-11-21 2007-05-24 Asubio Pharma Co., Ltd. Skin repair accelerating therapeutic agent containing ghrelin and derivatives thereof or substance acting on ghs-r1a as active ingredient
EP2012809B1 (en) * 2006-03-10 2013-05-22 Ipsen Pharma Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
NZ571183A (en) 2006-03-13 2010-09-30 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
AU2007281131B2 (en) * 2006-08-01 2012-11-29 The Scripps Research Institute Vaccines and methods for controlling adiposity
JPWO2008018600A1 (ja) 2006-08-11 2010-01-07 国立大学法人 宮崎大学 グレリン及びその誘導体又はＧＨＳ−Ｒ１ａに作用する物質を有効成分とする脊髄神経修復促進治療剤
JPWO2008018597A1 (ja) * 2006-08-11 2010-01-07 国立大学法人 宮崎大学 デスアシルグレリン及びその誘導体を有効成分とする脊髄神経修復促進治療剤
AU2007300526B2 (en) * 2006-09-27 2011-07-21 Ipsen Pharma S.A.S. Analogs of ghrelin substituted at the N-terminal
PT2277890E (pt) 2008-05-23 2016-03-31 Daiichi Sankyo Co Ltd Péptido capaz de prolongar o semi-período de vida do péptido de interesse no plasma
CN102348715B (zh) 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
US8883721B2 (en) * 2009-05-12 2014-11-11 Mcgill University Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
ES2599168T3 (es) 2010-01-15 2017-01-31 University Of Miyazaki Grelina para promover la recuperación de un animal en tratamiento médico
AU2011268256B8 (en) 2010-06-16 2016-12-22 Mcgill University Growth hormone secretatogue receptor antagonists and uses thereof
WO2012117592A1 (ja) 2011-03-03 2012-09-07 国立大学法人宮崎大学 高体温治療剤
JP5560248B2 (ja) * 2011-09-07 2014-07-23 花王株式会社 ジペプチド誘導体及びその製造方法
CN117462693A (zh) 2012-02-27 2024-01-30 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
MX349035B (es) 2012-05-17 2017-07-07 Extend Biosciences Inc Portadores para el suministro mejorado de farmaco.
EP2905029B1 (en) 2012-10-04 2018-11-21 Shionogi&Co., Ltd. Drug for inhibiting malignant tumor metastasis
CN104853778A (zh) * 2012-10-24 2015-08-19 第一三共株式会社 用于肌萎缩性侧索硬化的治疗剂
WO2014119753A1 (ja) * 2013-01-31 2014-08-07 学校法人 東京薬科大学 マイオスタチン阻害ペプチド
EP2979702A4 (en) * 2013-03-25 2016-11-16 Zeria Pharm Co Ltd POSTPRANDIAL GASTROKINETIC AGENT
US9585934B2 (en) 2014-10-22 2017-03-07 Extend Biosciences, Inc. Therapeutic vitamin D conjugates
US9789197B2 (en) 2014-10-22 2017-10-17 Extend Biosciences, Inc. RNAi vitamin D conjugates
WO2016065052A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Insulin vitamin d conjugates
CN109879935B (zh) * 2019-03-04 2020-11-20 南京工业大学 一种多肽的液相合成方法
US20230287040A1 (en) 2019-11-13 2023-09-14 Amunix Pharmaceuticals, Inc. Barcoded xten polypeptides and compositions thereof, and methods for making and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
CA2133834C (en) * 1992-04-07 2009-07-21 Stephen B.H. Kent Process for preparing modified proteins
IL118473A0 (en) 1995-06-02 1996-09-12 Suntory Ltd Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof
CA2198966C (en) 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
JP3982866B2 (ja) 1996-03-04 2007-09-26 アスビオファーマ株式会社 分泌型Ｋｅｘ２誘導体の製造方法
JP4335318B2 (ja) 1997-03-24 2009-09-30 ザイモジェネティクス，インコーポレイティド モチリン相同体
CA2328895A1 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6420521B1 (en) * 1999-06-30 2002-07-16 Zymogenetics, Inc. Short gastrointestinal peptides
ATE366813T1 (de) 1999-07-23 2007-08-15 Kenji Kangawa Neue peptide

Also Published As

Publication number Publication date
CN101693736B (zh) 2020-09-11
DE60035502T2 (de) 2008-03-20
CN1362968A (zh) 2002-08-07
BR0012688A (pt) 2002-04-16
AU784035B2 (en) 2006-01-19
JP4227857B2 (ja) 2009-02-18
CA2380058C (en) 2011-08-09
DE60035502D1 (de) 2007-08-23
US20110184153A1 (en) 2011-07-28
CA2380058A1 (en) 2001-02-01
BRPI0012688B8 (pt) 2021-05-25
CA2696819C (en) 2015-07-07
EP1197496A1 (en) 2002-04-17
ES2288151T3 (es) 2008-01-01
US8227570B2 (en) 2012-07-24
BRPI0012688B1 (pt) 2018-06-05
KR100827973B1 (ko) 2008-05-21
AU6023100A (en) 2001-02-13
EP1197496B8 (en) 2007-10-03
CN101693736A (zh) 2010-04-14
ES2335235T3 (es) 2010-03-23
US7385026B1 (en) 2008-06-10
AU2006201580A1 (en) 2006-05-18
EP1795598B1 (en) 2009-11-18
ES2401939T3 (es) 2013-04-25
DK1197496T3 (da) 2007-10-22
EP2119785B1 (en) 2013-03-13
EP1197496B1 (en) 2007-07-11
PT1197496E (pt) 2007-08-29
US9938332B2 (en) 2018-04-10
CY1109714T1 (el) 2014-08-13
US20100240866A1 (en) 2010-09-23
ATE449174T1 (de) 2009-12-15
JP2004000251A (ja) 2004-01-08
US20130172251A1 (en) 2013-07-04
PT1795598E (pt) 2010-01-05
JP3471780B2 (ja) 2003-12-02
EP1795598A1 (en) 2007-06-13
ATE366813T1 (de) 2007-08-15
US8524871B2 (en) 2013-09-03
KR20020026543A (ko) 2002-04-10
US9573986B2 (en) 2017-02-21
CN100506844C (zh) 2009-07-01
DK1795598T3 (da) 2010-02-01
DE60043361D1 (de) 2009-12-31
AU2006201580B2 (en) 2009-01-08
EP2119785A1 (en) 2009-11-18
EP1197496A4 (en) 2002-11-20
IL147652A (en) 2010-04-29
CA2696819A1 (en) 2001-02-01
CY1107724T1 (el) 2013-04-18
US20090170763A1 (en) 2009-07-02
WO2001007475A1 (fr) 2001-02-01

Similar Documents

Publication Publication Date Title
IL147652A0 (en) Novel peptides
PL370823A1 (en) Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors
ATE446758T1 (de) Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
AU2001272735A1 (en) Novel physiologically active peptide and use thereof
HK1056683A1 (en) New pharmaceutical composition
DE69220861D1 (de) Zyklische Peptide und ihre Verwendung
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
DE69723728D1 (de) Totalsynthese des amino hip analogen von didemnin a
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS
GB0207644D0 (en) Peptides and their use
EP1467207A4 (en) SCREENING PROCESS
EP1557466A4 (en) TUMOR ANTIGEN PROTEIN AND USE THEREOF
WO2002062944A2 (fr) Nouveau peptide physiologiquement actif et son utilisation
WO1999024470A8 (en) Mammalian milk growth factor
EP0821004A4 (en) NOVEL PEPTIDES AND MEDICINES FOR BONE DISEASES CONTAINING THESE PEPTIDES AS ACTIVE INGREDIENT
WO2001090139A3 (en) A ligand for enhancing oral and cns delivery of biological agents
WO2003022300A1 (fr) Remedes prophylactiques et curatifs contre les maladies des os et des articulations
EP1760087A4 (en) NEW PROTEIN COMPLEX AND USE OF THIS COMPLEX
YU17002A (sh) Upotreba deksrazoksana u lečenju psorijaze
WO2001021791A3 (en) Stargazin-like neuronal ca2+-channel gamma subunit polypeptides
WO2003038095A3 (fr) Peptide isole du facteur de croissance hepatocytaire et ses variants, procede de preparation et utilisation en therapeutique en tant qu'agents antiangiogeniques
BG106428A (en) Pharmaceutical compositions for treating psoriasis
WO2003029290A1 (fr) Transporteur de medicament et son utilisation
AU3562501A (en) Partners of ptb1 domain of fe65, preparation and uses